Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Ovarian Neoplasms

  Free Subscription

Articles published in Curr Opin Obstet Gynecol

Retrieve available abstracts of 12 articles:
HTML format

Single Articles

    February 2021
    PARP inhibitors in the treatment of ovarian cancer: a review.
    Curr Opin Obstet Gynecol. 2021;33:1-6.
    PubMed     Abstract available

    December 2019
    Latest clinical evidence of maintenance therapy in ovarian cancer.
    Curr Opin Obstet Gynecol. 2019 Dec 10. doi: 10.1097/GCO.0000000000000592.
    PubMed     Abstract available

  3. KUBALANZA K, Konecny GE
    Mechanisms of PARP inhibitor resistance in ovarian cancer.
    Curr Opin Obstet Gynecol. 2019 Dec 6. doi: 10.1097/GCO.0000000000000600.
    PubMed     Abstract available

    February 2019
    Poly-ADP-ribosyl-polymerase inhibitor resistance mechanisms and their therapeutic implications.
    Curr Opin Obstet Gynecol. 2019;31:12-17.
    PubMed     Abstract available

    December 2018
  5. STEWART D, Cristea M
    Antibody-drug conjugates for ovarian cancer: current clinical development.
    Curr Opin Obstet Gynecol. 2018 Dec 10. doi: 10.1097/GCO.0000000000000515.
    PubMed     Abstract available

    November 2018
  6. WINTERHOFF B, Talukdar S, Chang Z, Wang J, et al
    Single-cell sequencing in ovarian cancer: a new frontier in precision medicine.
    Curr Opin Obstet Gynecol. 2018 Nov 30. doi: 10.1097/GCO.0000000000000516.
    PubMed     Abstract available

  7. WASHINGTON C, Gunderson CC, Moore KN
    Update in the use and evaluation of poly (ADP-ribose) polymerase inhibitors in epithelial ovarian cancer: current and pending clinical research.
    Curr Opin Obstet Gynecol. 2018 Nov 15. doi: 10.1097/GCO.0000000000000507.
    PubMed     Abstract available

    February 2018
    Novel poly-ADP-ribose polymerase inhibitor combination strategies in ovarian cancer.
    Curr Opin Obstet Gynecol. 2018;30:7-16.
    PubMed     Abstract available

  9. VOLPE J, Filipi JG, Cooper OR, Penson RT, et al
    Frontline therapy of ovarian cancer: trials and tribulations.
    Curr Opin Obstet Gynecol. 2018;30:1-6.
    PubMed     Abstract available

    November 2017
  10. PALEARI L, DeCensi A
    Endocrine therapy in ovarian cancer: where do we stand?
    Curr Opin Obstet Gynecol. 2017 Nov 14. doi: 10.1097/GCO.0000000000000423.
    PubMed     Abstract available

    November 2016
  11. KROEGER PT JR, Drapkin R
    Pathogenesis and heterogeneity of ovarian cancer.
    Curr Opin Obstet Gynecol. 2016.
    PubMed     Abstract available

    February 2016
  12. WALSH CS, Hodeib M
    Leveraging DNA repair deficiency in gynecologic oncology.
    Curr Opin Obstet Gynecol. 2016;28:24-31.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.